5039 Cytochrome c oxidase subunit III-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 1 | 6.3 | 0.16× | q = 7.6e-3 | |
| Hydrocarbons | 2 | 0.1 | 22× | not tested | |
| Lipids and lipid-like molecules | 12 | 1.4 | 8.41× | not tested | |
| Organic oxygen compounds | 2 | 2.6 | 0.78× | not tested | |
| Homogeneous non-metal compounds | 2 | 2.8 | 0.72× | not tested | |
| Organic acids and derivatives | 1 | 2.0 | 0.50× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03429 | CDL | Tetrastearoyl cardiolipin | 148 |
| DB02659 | CHD | Cholic Acid | 127 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 9 |
| DB04327 | PEE | Phosphatidylethanolamine | 3 |
| DB09114 | PCF | Colfosceril palmitate | 2 |
| DB14522 | OH | Hydroxide ion | 2 |
| DB02043 | LHG | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole | 1 |
| DB03279 | LMU | Dodecyl-Alpha-D-Maltoside | 1 |
| DB04464 | — | N-Formylmethionine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CDL | CARDIOLIPIN | 203 |
| PGV | (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE | 165 |
| PEK | (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE | 161 |
| CHD | CHOLIC ACID | 150 |
| DMU | DECYL-BETA-D-MALTOPYRANOSIDE | 128 |
| UNX | UNKNOWN ATOM OR ION | 70 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 39 |
| NAmetal | SODIUM ION | 31 |
| LFA | EICOSANE | 22 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 21 |
| 9Y0 | (2R)-3-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-2-(palmitoyloxy)propyl (E)-octadec-9-enoate | 18 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 13 |
| PEF | DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE | 10 |
| 7PH | (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate | 8 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 8 |
| TRD | TRIDECANE | 8 |
| ZNmetal | ZINC ION | 8 |
| XE | XENON | 6 |
| PCF | 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE | 5 |
| CDmetal | CADMIUM ION | 4 |